Extendicare (TSE:EXE) Price Target Raised to C$44.00 at Canaccord Genuity Group

Extendicare (TSE:EXE) had its price target upped by investment analysts at Canaccord Genuity Group from C$37.00 to C$44.00 in a research note issued on Monday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price points to a potential upside of 36.69% from the stock’s current price.

Several other research analysts have also recently issued reports on EXE. BMO Capital Markets lifted their target price on shares of Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. TD boosted their price objective on shares of Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a report on Monday, May 11th. National Bank Financial increased their target price on Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. Finally, Desjardins lowered their target price on shares of Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company’s stock. Based on data from MarketBeat, Extendicare has an average rating of “Buy” and a consensus price target of C$35.44.

Extendicare Stock Down 0.8%

Extendicare stock traded down C$0.25 during mid-day trading on Monday, hitting C$32.19. The company had a trading volume of 363,614 shares, compared to its average volume of 388,127. Extendicare has a 12 month low of C$12.64 and a 12 month high of C$39.14. The company has a market capitalization of C$3.05 billion, a PE ratio of 23.69 and a beta of 1.59. The stock’s 50 day moving average price is C$35.24 and its two-hundred day moving average price is C$30.25. The company has a current ratio of 1.44, a quick ratio of 0.98 and a debt-to-equity ratio of 82.55.

Extendicare (TSE:EXE) last posted its quarterly earnings results on Thursday, August 6th. The company reported C$0.32 earnings per share (EPS) for the quarter. The firm had revenue of C$611.04 million during the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. As a group, sell-side analysts anticipate that Extendicare will post 0.6134729 earnings per share for the current fiscal year.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.